AP Professor Mark Schnitzer pioneers new imaging

Stanford Bio-X Seed Grant leads to first new clinical imaging platform in a quarter-century. A clinical imaging system recently designated by the FDA as a “breakthrough device” uses optical and AI technologies pioneered at Stanford to help diagnose skin cancers in real time.

Read Stanford News Report.
Image credit: Aaron Kehoe